S van Deventer

Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial

Daniel Gaudet, Julie Méthot, S. Déry et al. · Gene Therapy · 2012 · 399 citations · Full text

Medicine, Molecular Medicine, Pharmacology +14

Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78

Urs Widmer, Zhaohai Yang, S van Deventer et al. · The Journal of Immunology · 1991 · 46 citations

Life Sciences, Immunology, Molecular Biology +17

Safety, tolerance and efficacy of multiple doses of subcutaneous interleukin-10 in mild to moderate active Crohn's disease (STAMM-CD)

Alfred Gangl, C.O. Elson, Paul Rutgeerts et al. · Gastroenterology · 1998 · 22 citations

Life Sciences, Immunology, Pharmacotherapy +15

Duration of response following cessation of infliximab therapy for active or fistulizing Crohn's disease

G. D’Haens, Isolde Aerden, R. van Hogezand et al. · Gastroenterology · 1999 · 19 citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Anti-TNFα monoclonal antibody (cA2) produces endoscopic healing in patients with treatment-resistant, active Crohn's disease

G. D’Haens, S van Deventer, R. van Hogezand et al. · Gastroenterology · 1998 · 10 citations

Life Sciences, Clinical Sciences, Immunology +16